GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis
Status:
Completed
Trial end date:
2018-02-27
Target enrollment:
Participant gender:
Summary
A prospective, open, multicenter, randomized III trial with two arms:
- Arm A: Primary tumor resection , followed by chemotherapy
- Arm B: Chemotherapy alone. Compare overall 2-year survival rates in patients treated for
resectable rectal adenocarcinoma with unresectable metastasis, treated either with the
primary tumor resection with chemotherapy +/- target therapy, or with chemotherapy (+/-
target therapy) alone.